CA2391898A1 - Compositions and medical devices utilizing bioabsorbable polymeric waxes - Google Patents
Compositions and medical devices utilizing bioabsorbable polymeric waxes Download PDFInfo
- Publication number
- CA2391898A1 CA2391898A1 CA002391898A CA2391898A CA2391898A1 CA 2391898 A1 CA2391898 A1 CA 2391898A1 CA 002391898 A CA002391898 A CA 002391898A CA 2391898 A CA2391898 A CA 2391898A CA 2391898 A1 CA2391898 A1 CA 2391898A1
- Authority
- CA
- Canada
- Prior art keywords
- glycerol
- acid
- medical device
- group
- lactide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/14—Post-treatment to improve physical properties
- A61L17/145—Coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
Abstract
The present invention is directed to medical devices, pharmaceutical or agricultural compositions, and seeds, each containing a synthetic, bioabsorbable, biocompatible polymeric wax that is the reaction product of a polybasic acid or derivative thereof, a polyol and a fatty acid, the polymeric wax having a melting point less than about 70°C, as determined by differential scanning calorimetry.
Claims (58)
1. A medical device, comprising: a synthetic, bioabsorbable, biocompatible polymeric wax comprising the reaction product of a polybasic acid or derivative thereof, a fatty acid; and a polyol, said polymeric wax having a melting point less than about 70°C, as determined by differential scanning calorimetry.
2. The medical device of claim 1 wherein said polymeric wax comprises the reaction product of said polybasic acid or derivative thereof and a monoglyceride, said monoglyceride comprising the reaction product of said fatty acid and said polyol.
3. The medical device of claim 2 wherein said polybasic acid or derivative thereof is selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid, diglycolic anhydride, glutaric acid, glutaric anhydride, adipic acid, pimelic acid, suberic acid, sebacic acid, fumaric acid, maleic acid, maleic anhydride, mixed anhydrides, esters, activated esters and acid halides.
4. The medical device of claim 2 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
5. The medical device of claim 4 wherein said polybasic acid derivative is succinic anhydride.
6. The medical device of claim 4 wherein said polybasic acid is succinic acid.
7. The medical device of claim 1 wherein said polymeric wax has a number average molecular weight between about 1,000 g/mole and about 100,000 g/mole, as measured by gel permeation chromatography using polystyrene standards.
8. The medical device of claim 1 wherein said polymeric wax is branched.
9. The medical device of claim 1 wherein said polymeric wax comprises a copolymer.
10. The medical device of claim 9 wherein said polymeric wax copolymer comprises the reaction product of said fatty acid, said polyol, and at least two of said polybasic acids or derivatives thereof selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid and diglycolic anhydride.
11. The medical device of claim 9 wherein said polymeric wax copolymer comprises the reaction product of said polybasic acid or derivative thereof, and at least two monoglycerides selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
12. The medical device of claim 9 wherein said wax copolymer comprises the reaction product of said polybasic acid or derivative thereof, a monoglyceride selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol, and at least one additional polyol selected from the group consisting of ethylene glycol, 1,2-propylene glycol, 1,3-propanediol, bis-2-hydroxyethyl ether, 1,4-butanediol, 1,5-pentanediol, 1,6- hexanediol, 1,8-octanediol, 1,10-decanediol, 1, 12-dodecanediol, other diols, linear polyethylene glycol, branched poly(ethylene glycol), linear poly(propylene glycol), branched poly(propylene glycol), linear poly(ethylene-co-propylene glycol)s and branched polyethylene-co-propylene glycol)s.
13. The medical device of claim 1 further comprising an effective amount of a bioactive agent.
14. The medical device of claim 1 further comprising an aliphatic polyester prepared from monomers selected from the group consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, E-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
15. The medical device of claim 1 comprising a coating of said polymeric wax.
16. The medical device of claim 15 further comprising an aliphatic polyester prepared from the group of monomers consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, .epsilon.-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
17. The medical device of claim 1 comprising a bone replacement material comprising said polymeric wax and an inorganic filler.
18. The medical device of claim 17 wherein said polymeric wax is the reaction product of succinic anhydride and a monoglyceride selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
19. The medical device of claim 17 wherein said inorganic filler is selected from the group consisting of alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate and hydroxyapatite.
20. The medical device of claim 17 wherein said inorganic filler comprises a polymorph of calcium phosphate.
21. The medical device of claim 17 wherein said inorganic filler is hydroxyapatite.
22. The medical device of claim 17 further comprising a an effective amount of a bioactive agent.
23. The medical device of claim 22 wherein said bioactive agent is a growth factor.
24. The medical device of claim 17 wherein said bone replacement material comprises a biologically derived substance selected from the group consisting of demineralized bone, platelet rich plasma, bone marrow aspirate and bone fragments.
25. The medical device of claim 24 wherein said polymeric wax is the reaction product of succinic anhydride and a monoglyceride selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
26. The medical device of claim 24 wherein said inorganic filler is selected from the group consisting of alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate and hydroxyapatite.
27. The medical device of claim 24 wherein said bone replacement material further comprises an effective amount of a bioactive agent.
28. The medical device of claim 27 wherein the bioactive agent is a growth factor.
29. The medical device of claim 17 further comprising an aliphatic polyester prepared from the group of monomers consisting of glycolide, glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, .epsilon.-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
30. The medical device of claim 22 further comprising an aliphatic polyester prepared from the group of monomers consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, .epsilon.-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
31. The medical device of claim 1 selected from the group consisting of sutures, stents, vascular grafts, stent-graft combinations, meshes, tissue engineering scaffolds, pins, clips, staples, films, sheets, foams, anchors, screws and plates.
32. A composition, comprising: an effective amount of a bioactive agent, and a wax comprising the reaction product of a polybasic acid or derivative thereof, a fatty acid and a polyol, said wax having a melting point less than about 70°C, as determined by differential scanning calorimetry.
33. The composition of claim 32 wherein said polymeric wax comprises the reaction product of said polybasic acid or derivative thereof and a monoglyceride, said monoglyceride comprising the reaction product of said fatty acid and said polyol.
34. The composition of claim 32 wherein said polybasic acid or derivative thereof is selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid, diglycolic anhydride, glutaric acid, glutaric anhydride, adipic acid, pimelic acid, suberic acid, sebacic acid and derivatives thereof.
35. The composition of claim 33 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
36. The composition of claim 35 wherein said polybasic acid derivative is succinic anhydride.
37. The composition of claim 35 wherein said polybasic acid is succinic acid.
38. The composition of claim 32 wherein said polymeric wax has a number average molecular weight between about 1,000 g/mole and about 100,000 g/mole, as measured by gel permeation chromatography using polystyrene standards.
39. The composition of claim 32 wherein said polymeric wax is branched.
40. The composition of claim 32 wherein said polymeric wax comprises a copolymer.
41. The composition of claim 40 wherein said polymeric wax copolymer comprises the reaction product of said fatty acid, said polyol, and at least two of said polybasic acids or derivatives thereof selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid and diglycolic anhydride.
42. The composition of claim 40 wherein said polymeric wax copolymer comprises the reaction product of said polybasic acid or derivative thereof, and at least two monoglycerides selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
43. The composition of claim 40 wherein said polymeric wax copolymer comprises the reaction product of said polybasic acid or derivative thereof, a monoglyceride selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol, and at least one additional polyol selected from the group consisting of ethylene glycol, 1,2-propylene glycol, 1,3-propanediol, bis-2-hydroxyethyl ether, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,8-octanediol, 1,10-decanediol, 1, 12-dodecanediol, other diols, linear poly(ethylene glycol), branched poly(ethylene glycol), linear polypropylene glycol), branched poly(propylene glycol), linear poly(ethylene-co-propylene glycol)s and branched poly(ethylene-co-propylene glycol)s.
44. The composition of claim 32 wherein said bioactive agent is selected from the group consisting of antiinfectives, analgesics, anorexics, antihelmintics, antiarthritics, antiasthmatics, anticonvulsants, antidepressants, antidiuretics, antidiarrheals, antihistamines, antiinflammatory agents, antimigraine preparations, antinauseants, antineoplastics, antiparkinsonism drugs, antipruritics, antipsychotics, antipyretics, antispasmodics, anticholinergics, sympathomimetics, xanthine derivatives, calcium channel blockers, beta-blockers, antiarrhythmics, antihypertensives, diuretics, vasodilators, central nervous system stimulants,decongestants, hormones, steroids, hypnotics, immunosuppressives, muscle relaxants, parasympatholytics, psychostimulants, sedatives, tranquilizers, naturally derived or genetically engineered proteins, polysaccharides, glycoproteins, or lipoproteins, oligonucleotides, antibodies, antigens, cholinergics, chemotherapeutics, hemostatics, clot dissolving agents, radioactive agents and cystostatics.
45. The composition of claim 44 wherein said bioactive agent is risperidone.
46. The composition of claim 44 wherein said bioactive agent is erythropoietin.
47. The composition of claim 32 wherein said bioactive agent is selected from the group consisting of pesticides, insecticides, fungicides, germicides and fertilizers.
48. The composition of claim 32 further comprising an aliphatic polyester prepared from the group of monomers consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, .epsilon.-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
49. A seed comprising a coating of a synthetic, bioabsorbable, biocompatible polymeric wax comprising the reaction product of a polybasic acid or derivative thereof, a fatty acid, and a polyol, said polymeric wax having a melting point less than about 70°C, as determined by differential scanning calorimetry.
50. The seed of claim 49 wherein said polymeric wax comprises the reaction product of said polybasic acid or derivative thereof, and a monoglyceride, said monoglyceride comprising the reaction product of said fatty acid and said polyol.
51. The seed of claim 50 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
52. The seed of claim 50 wherein said polymeric wax comprises the reaction product of succinic anhydride and said monoglyceride selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.
53. The seed of claim 49 further comprising an aliphatic polyester prepared from the group of monomers consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, .epsilon.-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.
54. The seed of claim 49 wherein said polymeric wax further comprises an effective amount of a bioactive agent selected from the group consisting of pesticides, insecticides, fungicides, germicides and fertilizers.
55. The seed of claim 49 wherein said polymeric wax has a number average molecular weight between about 1,000 g/mole and about 100,000 g/mole, as measured by gel permeation chromatography using polystyrene standards.
56. The device of claim 1 wherein said polymeric wax has a melting point between about 25°C and about 70°C.
57. The composition of claim 32 wherein said polymeric wax has a melting point between about 25°C and about 70°C.
58. The seed of claim 49 wherein said polymeric wax has a melting point between about 25°C and about 70°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/896,004 US7030127B2 (en) | 2001-06-29 | 2001-06-29 | Composition and medical devices utilizing bioabsorbable polymeric waxes |
US09/896,004 | 2001-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2391898A1 true CA2391898A1 (en) | 2002-12-29 |
CA2391898C CA2391898C (en) | 2011-10-04 |
Family
ID=25405442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2391898A Expired - Fee Related CA2391898C (en) | 2001-06-29 | 2002-06-27 | Compositions and medical devices utilizing bioabsorbable polymeric waxes |
Country Status (12)
Country | Link |
---|---|
US (4) | US7030127B2 (en) |
EP (1) | EP1270024B1 (en) |
KR (1) | KR20030003095A (en) |
CN (1) | CN1212865C (en) |
AT (1) | ATE322917T1 (en) |
AU (1) | AU784171B2 (en) |
CA (1) | CA2391898C (en) |
DE (1) | DE60210539T2 (en) |
DK (1) | DK1270024T3 (en) |
ES (1) | ES2261601T3 (en) |
PT (1) | PT1270024E (en) |
TW (1) | TWI309574B (en) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US6967234B2 (en) | 2002-12-18 | 2005-11-22 | Ethicon, Inc. | Alkyd-lactone copolymers for medical applications |
US7034037B2 (en) | 2001-06-29 | 2006-04-25 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin |
US7030127B2 (en) * | 2001-06-29 | 2006-04-18 | Ethicon, Inc. | Composition and medical devices utilizing bioabsorbable polymeric waxes |
WO2003015800A1 (en) * | 2001-08-09 | 2003-02-27 | Ivoclar Vivadent, Inc. | Tissue implants and methods for making and using same |
US7722894B2 (en) * | 2001-10-22 | 2010-05-25 | Massachusetts Institute Of Technology | Biodegradable polymer |
US8460693B2 (en) * | 2001-11-08 | 2013-06-11 | Atrium Medical Corporation | Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent |
US20040127563A1 (en) * | 2002-03-22 | 2004-07-01 | Deslauriers Richard J. | Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
US7326426B2 (en) * | 2002-03-29 | 2008-02-05 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable liquid polymers |
US7005136B2 (en) | 2002-03-29 | 2006-02-28 | Ethicon, Inc. | Bone replacement materials utilizing bioabsorbable liquid polymers |
US7368125B2 (en) * | 2002-06-05 | 2008-05-06 | Ethicon, Inc. | Amphiphilic polymers for medical applications |
US7026374B2 (en) * | 2002-06-25 | 2006-04-11 | Aruna Nathan | Injectable microdispersions for medical applications |
US7101566B2 (en) * | 2002-06-28 | 2006-09-05 | Ethicon, Inc. | Polymer coated microparticles for sustained release |
DE10254215B4 (en) * | 2002-11-20 | 2014-10-09 | Johnson & Johnson Medical Gmbh | Surgical implant |
US6872799B2 (en) | 2002-12-18 | 2005-03-29 | Ethicon, Inc. | Functionalized polymers for medical applications |
US6866860B2 (en) * | 2002-12-19 | 2005-03-15 | Ethicon, Inc. | Cationic alkyd polyesters for medical applications |
US20040120981A1 (en) * | 2002-12-20 | 2004-06-24 | Aruna Nathan | Crosslinked alkyd polyesters for medical applications |
WO2004096178A1 (en) * | 2003-05-02 | 2004-11-11 | The University Of Nottingham | Nano and microparticle drug delivery systems comprising polyesters containing aliphatic dicarboxylate residues and residues of aliphatic polyols |
US7220433B2 (en) | 2003-06-27 | 2007-05-22 | Ethicon, Inc. | Compositions for parenteral administration and sustained-release of therapeutic agents |
US9592324B2 (en) * | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
US9801982B2 (en) * | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US8858978B2 (en) | 2004-09-28 | 2014-10-14 | Atrium Medical Corporation | Heat cured gel and method of making |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US20090011116A1 (en) * | 2004-09-28 | 2009-01-08 | Atrium Medical Corporation | Reducing template with coating receptacle containing a medical device to be coated |
US8367099B2 (en) * | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9012506B2 (en) * | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US20060083768A1 (en) * | 2004-09-28 | 2006-04-20 | Atrium Medical Corporation | Method of thickening a coating using a drug |
US20060088596A1 (en) | 2004-09-28 | 2006-04-27 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) * | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US20090011486A1 (en) * | 2006-01-12 | 2009-01-08 | Massachusetts Institute Of Technology | Biodegradable Elastomers |
WO2007082304A2 (en) | 2006-01-12 | 2007-07-19 | Massachusetts Institute Of Technology | Biodegradable elastomers |
US20070224245A1 (en) | 2006-02-08 | 2007-09-27 | Northwestern University | Poly (diol co-citrate) hydroxyapatite composite for tissue engineering and orthopaedic fixation devices |
EP1916006A1 (en) * | 2006-10-19 | 2008-04-30 | Albert Schömig | Implant coated with a wax or a resin |
EP1913960A1 (en) * | 2006-10-19 | 2008-04-23 | Albert Schömig | Coated implant |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
EP2500015A1 (en) * | 2006-12-05 | 2012-09-19 | Landec Corporation | Delivery of drugs |
US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
JP5512280B2 (en) | 2006-12-28 | 2014-06-04 | スリーエム イノベイティブ プロパティズ カンパニー | Dental filler and method |
WO2008144514A2 (en) * | 2007-05-17 | 2008-11-27 | Massachusetts Institute Of Technology | Polyol-based polymers |
KR20110042107A (en) | 2008-08-07 | 2011-04-22 | 바이오엑티브 써지컬, 아이엔씨. | Stem cell capture and immobilization coatings for medical devices and implants |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9801831B2 (en) | 2010-12-30 | 2017-10-31 | Nanyang Technological University | Device for controlled release of a bioactive agent |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US9522189B2 (en) | 2013-12-20 | 2016-12-20 | Johnson & Johnson Consumer Inc. | Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent |
DE102014005782A1 (en) * | 2014-04-23 | 2015-10-29 | Martin-Luther-Universität Halle-Wittenberg | Injectable and implantable carrier systems based on modified poly (dicarboxylic acid multiol esters) for controlled release of active ingredient |
EP4261523A3 (en) * | 2014-10-14 | 2023-12-06 | Becton, Dickinson and Company | Blood sample management using open cell foam |
US9688943B2 (en) | 2015-05-29 | 2017-06-27 | beauty Avenues LLC | Candle containing non-ionic emulsifer |
CN105852926B (en) * | 2015-12-31 | 2019-03-08 | 江苏风和医疗器材股份有限公司 | A kind of production method of medical snare |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2895930A (en) * | 1955-06-28 | 1959-07-21 | Bradley & Vrooman Company | Water emulsion of polymerizable epoxide group containing oil modified alkyd and formaldehyde condensation resins |
US3806479A (en) * | 1972-06-14 | 1974-04-23 | Sherwin Williams Co | Ester-containing liquid polyols |
US3997512A (en) * | 1973-11-21 | 1976-12-14 | American Cyanamid Company | High molecular weight polyester resin, the method of making the same |
US3978203A (en) * | 1974-07-12 | 1976-08-31 | Dynatech Corporation | Sustained release of pharmaceuticals from polyester matrices |
US4076798A (en) * | 1975-05-29 | 1978-02-28 | American Cyanamid Company | High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition |
US4118470A (en) * | 1976-06-01 | 1978-10-03 | American Cyanamid Company | Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product |
US4122129A (en) * | 1976-06-01 | 1978-10-24 | American Cyanamid Company | Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product |
US4048256A (en) * | 1976-06-01 | 1977-09-13 | American Cyanamid Company | Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product |
US4095600A (en) * | 1976-06-01 | 1978-06-20 | American Cyanamid Company | Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
DE3041073C2 (en) * | 1980-10-31 | 1986-01-02 | Dynamit Nobel Ag, 5210 Troisdorf | Wool wax substitutes |
US4419139A (en) * | 1982-03-24 | 1983-12-06 | University Of Southern Mississippi | Process for preparing coating binders from vegetable oil material |
US4568559A (en) * | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5306311A (en) * | 1987-07-20 | 1994-04-26 | Regen Corporation | Prosthetic articular cartilage |
EP0404806B1 (en) | 1988-03-14 | 1992-03-11 | Novo Nordisk A/S | Stabilized particulate composition |
DE3825211A1 (en) * | 1988-07-25 | 1990-02-01 | Henkel Kgaa | IMPROVED BODY RESORBONABLE WAXES (III) |
AU636346B2 (en) | 1989-04-25 | 1993-04-29 | Children's Hospital | Method for implanting large volumes of cells on polymeric matrices |
US5137743A (en) * | 1990-09-07 | 1992-08-11 | Opta Food Ingredients, Inc. | Foods having an oil phase thickened with an oil soluble polyester |
DK13491D0 (en) | 1991-01-25 | 1991-01-25 | Novo Nordisk As | APPLICATION OF AN ENZYMOUS GRANULATE AND PROCEDURE FOR PREPARING A TABLET FORM |
US5879920A (en) | 1991-10-07 | 1999-03-09 | Genencor International, Inc. | Coated enzyme-containing granule |
JPH05194189A (en) * | 1991-10-23 | 1993-08-03 | Boehringer Ingelheim Kg | Semisolid mixture of oligomer and/or polymer based on lactic acid, method for production thereof and use thereof as absorptive insert |
EP0610423B1 (en) | 1991-10-30 | 1997-05-07 | Massachusetts Institute Of Technology | Prevascularized polymeric implants for organ transplantation |
US5219980A (en) * | 1992-04-16 | 1993-06-15 | Sri International | Polymers biodegradable or bioerodiable into amino acids |
AU4198793A (en) * | 1992-07-24 | 1994-01-27 | Takeda Chemical Industries Ltd. | Microparticle preparation and production thereof |
CZ278863B6 (en) * | 1992-09-07 | 1994-07-13 | Galena | Medicinal preparations with n-methylated cyclic undecapeptides |
DE4243904A1 (en) | 1992-12-23 | 1994-06-30 | Roth Technik Gmbh | catalyst |
JPH06211651A (en) | 1993-01-12 | 1994-08-02 | Hisamitsu Pharmaceut Co Inc | Composition for treating nail trichophytosis |
WO1994025079A1 (en) | 1993-04-23 | 1994-11-10 | Massachusetts Institute Of Technology | Porous biodegradable polymeric materials for cell transplantation |
US5411554A (en) * | 1993-07-20 | 1995-05-02 | Ethicon, Inc. | Liquid polymer filled envelopes for use as surgical implants |
JP3220331B2 (en) * | 1993-07-20 | 2001-10-22 | エチコン・インコーポレーテツド | Absorbable liquid copolymers for parenteral administration |
US5442033A (en) * | 1993-07-20 | 1995-08-15 | Ethicon, Inc. | Liquid copolymers of epsilon-caprolactone and lactide |
US5359026A (en) * | 1993-07-30 | 1994-10-25 | Cargill, Incorporated | Poly(lactide) copolymer and process for manufacture thereof |
JPH07112940A (en) * | 1993-08-26 | 1995-05-02 | Takeda Chem Ind Ltd | Sustained-release parenteral preparation and its production |
US6149953A (en) * | 1993-11-08 | 2000-11-21 | Delta Food Group, Inc. | Seeded microcapsules |
WO1995022318A1 (en) | 1994-02-17 | 1995-08-24 | Pankaj Modi | Drugs, vaccines and hormones in polylactide coated microspheres |
US5599852A (en) * | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
AU706434B2 (en) * | 1994-10-18 | 1999-06-17 | Ethicon Inc. | Injectable liquid copolymers for soft tissue repair and augmentation |
US6335383B1 (en) * | 1994-10-18 | 2002-01-01 | Ethicon, Inc. | Microdispersions for coating surgical devices |
US5859150A (en) * | 1995-03-06 | 1999-01-12 | Ethicon, Inc. | Prepolymers of absorbable polyoxaesters |
US6100346A (en) * | 1995-03-06 | 2000-08-08 | Ethicon, Inc. | Copolymers of polyoxaamides |
US5698213A (en) * | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters |
US5700583A (en) * | 1995-03-06 | 1997-12-23 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters containing amines or amido groups |
US5607687A (en) * | 1995-03-06 | 1997-03-04 | Ethicon, Inc. | Polymer blends containing absorbable polyoxaesters |
US6147168A (en) * | 1995-03-06 | 2000-11-14 | Ethicon, Inc. | Copolymers of absorbable polyoxaesters |
US5464929A (en) * | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters |
US5618552A (en) * | 1995-03-06 | 1997-04-08 | Ethicon, Inc. | Absorbable polyoxaesters |
US5962023A (en) * | 1995-03-06 | 1999-10-05 | Ethicon, Inc. | Hydrogels containing absorbable polyoxaamides |
KR100201352B1 (en) * | 1995-03-16 | 1999-06-15 | 성재갑 | Single shot vaccine formulation |
US5641502A (en) | 1995-06-07 | 1997-06-24 | United States Surgical Corporation | Biodegradable moldable surgical material |
GB9602638D0 (en) | 1995-09-07 | 1996-04-10 | Croda Int Plc | Triglyceride drying oil derivatives |
SE505146C2 (en) * | 1995-10-19 | 1997-06-30 | Biogram Ab | Particles for delayed release |
EP0904031A4 (en) * | 1996-05-29 | 2002-05-02 | Cell Genesys Inc | Cationic polymer/lipid nucleic acid delivery vehicles |
US6121398A (en) * | 1997-10-27 | 2000-09-19 | University Of Delaware | High modulus polymers and composites from plant oils |
ZA9811376B (en) | 1997-12-12 | 1999-06-28 | Expression Genetics Inc | Biodegradable mixed polymeric micelles for gene delivery |
JP3483753B2 (en) * | 1997-12-29 | 2004-01-06 | タキロン株式会社 | Biodegradable absorbent plastic adhesive |
US6074660A (en) * | 1998-04-20 | 2000-06-13 | Ethicon, Inc. | Absorbable polyoxaesters containing amines and/ or amido groups |
US6268329B1 (en) * | 1998-06-30 | 2001-07-31 | Nouozymes A/S | Enzyme containing granule |
AU5100899A (en) | 1998-07-13 | 2000-02-01 | Expression Genetics, Inc. | Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
US6114458A (en) * | 1998-09-23 | 2000-09-05 | International Business Machines Corporation | Highly branched radial block copolymers |
JP2002532160A (en) | 1998-12-17 | 2002-10-02 | ケンブリッジ サイエンティフィック, インコーポレイテッド | Ordered integration of cortical bone allografts |
CA2359318C (en) | 1999-02-01 | 2009-06-30 | Donald Elbert | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
IL131074A0 (en) | 1999-07-23 | 2001-03-19 | Polygene Ltd | A biodegradable polycation composition for delivery of an anionic macromolecule |
SE520688C2 (en) * | 2000-04-11 | 2003-08-12 | Bone Support Ab | An injectable bone mineral replacement material |
FR2810236B1 (en) * | 2000-06-15 | 2002-07-26 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
US6967234B2 (en) * | 2002-12-18 | 2005-11-22 | Ethicon, Inc. | Alkyd-lactone copolymers for medical applications |
US7030127B2 (en) * | 2001-06-29 | 2006-04-18 | Ethicon, Inc. | Composition and medical devices utilizing bioabsorbable polymeric waxes |
US7034037B2 (en) * | 2001-06-29 | 2006-04-25 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin |
US7326426B2 (en) * | 2002-03-29 | 2008-02-05 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable liquid polymers |
US7005136B2 (en) * | 2002-03-29 | 2006-02-28 | Ethicon, Inc. | Bone replacement materials utilizing bioabsorbable liquid polymers |
US7368125B2 (en) * | 2002-06-05 | 2008-05-06 | Ethicon, Inc. | Amphiphilic polymers for medical applications |
US7026374B2 (en) * | 2002-06-25 | 2006-04-11 | Aruna Nathan | Injectable microdispersions for medical applications |
US7101566B2 (en) * | 2002-06-28 | 2006-09-05 | Ethicon, Inc. | Polymer coated microparticles for sustained release |
US6866860B2 (en) * | 2002-12-19 | 2005-03-15 | Ethicon, Inc. | Cationic alkyd polyesters for medical applications |
-
2001
- 2001-06-29 US US09/896,004 patent/US7030127B2/en not_active Expired - Lifetime
-
2002
- 2002-06-25 AU AU48943/02A patent/AU784171B2/en not_active Ceased
- 2002-06-27 CA CA2391898A patent/CA2391898C/en not_active Expired - Fee Related
- 2002-06-28 KR KR1020020036976A patent/KR20030003095A/en not_active Application Discontinuation
- 2002-06-28 PT PT02254564T patent/PT1270024E/en unknown
- 2002-06-28 AT AT02254564T patent/ATE322917T1/en not_active IP Right Cessation
- 2002-06-28 DK DK02254564T patent/DK1270024T3/en active
- 2002-06-28 DE DE60210539T patent/DE60210539T2/en not_active Expired - Lifetime
- 2002-06-28 ES ES02254564T patent/ES2261601T3/en not_active Expired - Lifetime
- 2002-06-28 EP EP02254564A patent/EP1270024B1/en not_active Expired - Lifetime
- 2002-06-28 TW TW091114247A patent/TWI309574B/en active
- 2002-06-29 CN CNB021286183A patent/CN1212865C/en not_active Expired - Fee Related
-
2006
- 2006-03-10 US US11/342,097 patent/US20060141005A1/en not_active Abandoned
- 2006-03-10 US US11/341,394 patent/US20060141004A1/en not_active Abandoned
- 2006-05-05 US US11/340,882 patent/US20060210747A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4894302A (en) | 2003-01-02 |
US20060141005A1 (en) | 2006-06-29 |
EP1270024A1 (en) | 2003-01-02 |
CN1394652A (en) | 2003-02-05 |
TWI309574B (en) | 2009-05-11 |
DK1270024T3 (en) | 2006-06-26 |
US20060210747A1 (en) | 2006-09-21 |
KR20030003095A (en) | 2003-01-09 |
EP1270024B1 (en) | 2006-04-12 |
PT1270024E (en) | 2006-07-31 |
CN1212865C (en) | 2005-08-03 |
AU784171B2 (en) | 2006-02-16 |
DE60210539T2 (en) | 2007-04-05 |
ATE322917T1 (en) | 2006-04-15 |
DE60210539D1 (en) | 2006-05-24 |
US20060141004A1 (en) | 2006-06-29 |
US20030003125A1 (en) | 2003-01-02 |
ES2261601T3 (en) | 2006-11-16 |
US7030127B2 (en) | 2006-04-18 |
CA2391898C (en) | 2011-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2391898A1 (en) | Compositions and medical devices utilizing bioabsorbable polymeric waxes | |
CA2431241A1 (en) | Amphiphilic polymers for medical applications | |
CA2453779A1 (en) | Cationic alkyd polyesters for medical applications | |
CA2423999A1 (en) | Compositions and medical devices utilizing bioabsorbable liquid polymers | |
CA2453892A1 (en) | Alkyd-lactone copolymers for medical applications | |
EP1430917B1 (en) | Compositions and medical devices utilizing bioabsorbable polymeric waxes | |
CA2433679A1 (en) | Polymer coated microparticles for sustained release | |
CA2452951A1 (en) | Functionalized polymers for medical applications | |
AU595235B2 (en) | Caprolactone polymer for suture coating | |
JP4850437B2 (en) | Medical implant containing an encapsulated buffer | |
CA2433244A1 (en) | Injectable microdispersions for medical applications | |
JP5318318B2 (en) | Biodegradable endovascular device containing buffer | |
US5468252A (en) | Packaged synthetic absorbable surgical elements | |
US5889075A (en) | Irradiated surgical suture and method for making same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140627 |